NCT02259920View on ClinicalTrials.gov

Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

KUC 7483 CL, immediate release tablet

DRUG

KUC 7483 CL, particulate formulation

DRUG

KUC 7483 CL, solution formulation

DEVICE

Enterion™ capsule

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02259920 - Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter